logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Prothena Corporation Plc Appoints Chad Swanson As Chief Development Officer and Hideki Garren Pursues Opportunity At Another Company

Sep 27, 2024•about 1 year ago

Position

Chief Development Officer

Company

Prothena Corporation

Chad Swanson
DublinTherapeuticsBiotechnologyHealth Care

Description

Prothena Corporation plc announced the appointment of Chad Swanson, Ph.D., as Chief Development Officer, succeeding Hideki Garren, M.D., Ph.D. Hideki Garren, M.D., Ph.D., will pursue an opportunity at a large pharmaceutical company to lead a global product development division. Prothena will also initiate a search for a world-class healthcare leader as the next Chief Medical Officer.

Company Information

Company

Prothena Corporation

Location

Dublin, Dublin, Ireland

About

Prothena Corporation plc is a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise. The company is focused on advancing a promising pipeline in neurodegenerative and rare peripheral amyloid diseases, guided by patient-focused drug development.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months